Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: The CRESCEND study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Su-Jin | - |
dc.contributor.author | Kim, Sun-Young | - |
dc.contributor.author | Stewart, Robert | - |
dc.contributor.author | Kim, Jae-Min | - |
dc.contributor.author | Shin, Il-Seon | - |
dc.contributor.author | Jung, Sung-Won | - |
dc.contributor.author | Lee, Min-Soo | - |
dc.contributor.author | Jeong, Seung-Hee | - |
dc.contributor.author | Jun, Tae-Youn | - |
dc.date.accessioned | 2021-09-07T09:08:48Z | - |
dc.date.available | 2021-09-07T09:08:48Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2011-08-30 | - |
dc.identifier.issn | 0165-1781 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/111756 | - |
dc.description.abstract | This study aimed to determine whether men and women with depression differ in socio-demographic, treatment-related characteristics, and in their responses to treatment with antidepressants, as well as to explore differences in treatment outcomes by menopausal status. From a nationwide sample of 18 hospitals in South Korea, 723 depressive patients were recruited. After baseline evaluation, they received naturalistic clinician-determined antidepressant interventions. Assessment scales for evaluating depression (HAMD), anxiety (HAMA), global severity (CGI-s), and functioning (SOFAS) were administered at baseline and re-evaluated at 1, 2, 4, 8, and 12 weeks later. At baseline, women were older, less educated, less likely to be employed, had lower income, were more likely to be married, and had longer illness duration than men. There were no gender differences in the treatment-regime received. After adjustment for baseline status, women were more likely to achieve HAMD remission (OR = 1.51), HAMD response (OR = 1.64), and HAMA response (OR = 1.61). Women also experienced shorter times to HAMD response, HAMA response, and CGI-s remission. Postmenopausal women showed higher HAMA response with newer dual action antidepressants than premenopausal women. Women were found to have better outcomes following antidepressant treatment than men, and postmenopausal women had a better response on anxiety symptoms with newer dual action antidepressants. (C) 2010 Elsevier Ireland Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.subject | SEX-DIFFERENCES | - |
dc.subject | MAJOR DEPRESSION | - |
dc.subject | PSYCHIATRIC-DISORDERS | - |
dc.subject | 12-MONTH PREVALENCE | - |
dc.subject | TREATMENT RESPONSE | - |
dc.subject | UNITED-STATES | - |
dc.subject | IMIPRAMINE | - |
dc.subject | SERTRALINE | - |
dc.subject | RECOVERY | - |
dc.subject | LIFETIME | - |
dc.title | Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: The CRESCEND study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Min-Soo | - |
dc.identifier.doi | 10.1016/j.psychres.2010.12.027 | - |
dc.identifier.scopusid | 2-s2.0-79958096715 | - |
dc.identifier.wosid | 000295073500014 | - |
dc.identifier.bibliographicCitation | PSYCHIATRY RESEARCH, v.189, no.1, pp.82 - 90 | - |
dc.relation.isPartOf | PSYCHIATRY RESEARCH | - |
dc.citation.title | PSYCHIATRY RESEARCH | - |
dc.citation.volume | 189 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 82 | - |
dc.citation.endPage | 90 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | SEX-DIFFERENCES | - |
dc.subject.keywordPlus | MAJOR DEPRESSION | - |
dc.subject.keywordPlus | PSYCHIATRIC-DISORDERS | - |
dc.subject.keywordPlus | 12-MONTH PREVALENCE | - |
dc.subject.keywordPlus | TREATMENT RESPONSE | - |
dc.subject.keywordPlus | UNITED-STATES | - |
dc.subject.keywordPlus | IMIPRAMINE | - |
dc.subject.keywordPlus | SERTRALINE | - |
dc.subject.keywordPlus | RECOVERY | - |
dc.subject.keywordPlus | LIFETIME | - |
dc.subject.keywordAuthor | Gender differences | - |
dc.subject.keywordAuthor | Antidepressants | - |
dc.subject.keywordAuthor | Depression | - |
dc.subject.keywordAuthor | Treatment outcome | - |
dc.subject.keywordAuthor | Korea | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.